Cardiovascular Pharmacotherapeutics

The definitive guide for practicing physicians and pharmacists who need to know about drug therapy for heart conditions. The fully updated Second Edition explores mechanisms of action, all the cardiovascular agents now available, drugs in development, molecular biological advances, and specific drug treatments.

Descripción

The definitive reference covering drug therapy of cardiovascular conditions! This comprehensive text describes both current and future developments regarding drug therapy for all cardiovascular diseases. Updated to cover the latest basic science information, drugs in development, and molecular biological advances. An in-depth review of all the cardiovascular agents currently on the market is also included

Tabla de Contenidos

Part 1 Introductory Chapters

• 1. Basic Principles
• 2. Placebo Effect
• 3. Compliance
• 4. New Drug Development
• 5. Pharmacoeconomics
• 6. Cardiovascular Pharm History

Part 2 Drug Classes

• 7. Alpha & Beta blockers
• 8. Cholinergic & Anticholinergic Drugs
• 9. Calcium blockers
• 10. RAS ¿ ACE, ARBs
• 11. Diuretic
• 12. Mag, K+, Calcium
• 13. Digitalis and Inotropic Agents
• 14. Organic Nitrates and nitroprusside
• 15. Central Action, Ganglionic blockers, neuron depletors
• 16. Nonspecific antihypertensive vasodilators
• 17. Antiarrhythmics
• 18. Antiplatelets & Antithrombotics
• 19. Thrombolytics
• 20. Lipid lowering/effects of CV drugs on lipoproteins
• 21. Combination
• 22. Smoking, nicotine
• 23. Fish oils
• 24. Antioxidant vitamins and free radical scavengers
• 25. Prostacyclin
• 26. Dopamine

Part 3 New Drugs Classes in Development

• 27. Natriuretic peptides and neutral endopeptidase
• 28. Potassium channel and sodium-hydrogen channel
• 29. Serotonin
• 30. Imidazoline
• 31. Endothelin
• 32. Adenosine
• 33. Nitric oxide
• 34. Renin
• 35. Vasopressin
• 36. Hormones
• 37. Innovative approaches for myocardial ischemia ¿ focus on angiogenesis
• 38. Angiogenesis
• 39. Innovative drug targets
• 40. Restenosis
• 41. Gene therapy
• 42. Apoptosis
• 43. Matrix Metalloproteinase
• 44. NSAIDS & Cox 2 inhibitors
• 45. Prostaglandins & P450 Metabolites
• 46. Innovative med. approaches to hyperlipidemia